Viscofan Balance Sheet Health

Financial Health criteria checks 5/6

Viscofan has a total shareholder equity of €956.2M and total debt of €265.6M, which brings its debt-to-equity ratio to 27.8%. Its total assets and total liabilities are €1.4B and €477.9M respectively. Viscofan's EBIT is €183.8M making its interest coverage ratio 29.5. It has cash and short-term investments of €58.3M.

Key information

27.8%

Debt to equity ratio

€265.57m

Debt

Interest coverage ratio29.5x
Cash€58.26m
Equity€956.17m
Total liabilities€477.88m
Total assets€1.43b

Recent financial health updates

Recent updates

Viscofan, S.A. (BME:VIS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Apr 20
Viscofan, S.A. (BME:VIS) First-Quarter Results: Here's What Analysts Are Forecasting For This Year

Why We Think Viscofan, S.A.'s (BME:VIS) CEO Compensation Is Not Excessive At All

Apr 11
Why We Think Viscofan, S.A.'s (BME:VIS) CEO Compensation Is Not Excessive At All

Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 38% Undervaluation?

Apr 04
Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 38% Undervaluation?

Some Shareholders Feeling Restless Over Viscofan, S.A.'s (BME:VIS) P/E Ratio

Mar 18
Some Shareholders Feeling Restless Over Viscofan, S.A.'s (BME:VIS) P/E Ratio

Slowing Rates Of Return At Viscofan (BME:VIS) Leave Little Room For Excitement

Jan 17
Slowing Rates Of Return At Viscofan (BME:VIS) Leave Little Room For Excitement

Is Viscofan (BME:VIS) Using Too Much Debt?

Dec 21
Is Viscofan (BME:VIS) Using Too Much Debt?

Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 37% Undervaluation?

Nov 15
Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 37% Undervaluation?

Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Sep 20
Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Returns On Capital At Viscofan (BME:VIS) Have Stalled

Aug 29
Returns On Capital At Viscofan (BME:VIS) Have Stalled

Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 32% Undervaluation?

Aug 11
Is There An Opportunity With Viscofan, S.A.'s (BME:VIS) 32% Undervaluation?

Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly

May 25
Here's Why Viscofan (BME:VIS) Can Manage Its Debt Responsibly

Viscofan's (BME:VIS) Dividend Will Be Increased To €0.4374

May 04
Viscofan's (BME:VIS) Dividend Will Be Increased To €0.4374

Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching

Apr 24
Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching

The Returns At Viscofan (BME:VIS) Aren't Growing

Mar 02
The Returns At Viscofan (BME:VIS) Aren't Growing

Estimating The Intrinsic Value Of Viscofan, S.A. (BME:VIS)

Feb 16
Estimating The Intrinsic Value Of Viscofan, S.A. (BME:VIS)

Is Viscofan (BME:VIS) Using Too Much Debt?

Jan 07
Is Viscofan (BME:VIS) Using Too Much Debt?

Returns On Capital At Viscofan (BME:VIS) Have Stalled

Nov 29
Returns On Capital At Viscofan (BME:VIS) Have Stalled

Viscofan, S.A.'s (BME:VIS) Intrinsic Value Is Potentially 77% Above Its Share Price

Nov 11
Viscofan, S.A.'s (BME:VIS) Intrinsic Value Is Potentially 77% Above Its Share Price

Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Sep 01
Viscofan (BME:VIS) Has A Pretty Healthy Balance Sheet

Viscofan (BME:VIS) Has Some Way To Go To Become A Multi-Bagger

Aug 03
Viscofan (BME:VIS) Has Some Way To Go To Become A Multi-Bagger

Viscofan's (BME:VIS) Returns Have Hit A Wall

May 03
Viscofan's (BME:VIS) Returns Have Hit A Wall

Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?

Mar 25
Does Viscofan (BME:VIS) Have A Healthy Balance Sheet?

Is Viscofan, S.A. (BME:VIS) Trading At A 38% Discount?

Mar 06
Is Viscofan, S.A. (BME:VIS) Trading At A 38% Discount?

Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching

Jan 15
Here's Why We Think Viscofan (BME:VIS) Is Well Worth Watching

Returns At Viscofan (BME:VIS) Appear To Be Weighed Down

Dec 29
Returns At Viscofan (BME:VIS) Appear To Be Weighed Down

Viscofan (BME:VIS) Has A Rock Solid Balance Sheet

Nov 24
Viscofan (BME:VIS) Has A Rock Solid Balance Sheet

Is Viscofan, S.A. (BME:VIS) Trading At A 24% Discount?

Oct 10
Is Viscofan, S.A. (BME:VIS) Trading At A 24% Discount?

With EPS Growth And More, Viscofan (BME:VIS) Is Interesting

Sep 23
With EPS Growth And More, Viscofan (BME:VIS) Is Interesting

Returns On Capital At Viscofan (BME:VIS) Have Stalled

Aug 19
Returns On Capital At Viscofan (BME:VIS) Have Stalled

Viscofan (BME:VIS) Has A Rock Solid Balance Sheet

Aug 03
Viscofan (BME:VIS) Has A Rock Solid Balance Sheet

A Look At The Fair Value Of Viscofan, S.A. (BME:VIS)

May 17
A Look At The Fair Value Of Viscofan, S.A. (BME:VIS)

Viscofan (BME:VIS) Could Easily Take On More Debt

Apr 07
Viscofan (BME:VIS) Could Easily Take On More Debt

Should We Be Excited About The Trends Of Returns At Viscofan (BME:VIS)?

Mar 04
Should We Be Excited About The Trends Of Returns At Viscofan (BME:VIS)?

Here's What Viscofan, S.A.'s (BME:VIS) Shareholder Ownership Structure Looks Like

Feb 17
Here's What Viscofan, S.A.'s (BME:VIS) Shareholder Ownership Structure Looks Like

Viscofan, S.A.'s (BME:VIS) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

Feb 02
Viscofan, S.A.'s (BME:VIS) Stock Has Shown A Decent Performance: Have Financials A Role To Play?

A Look At The Intrinsic Value Of Viscofan, S.A. (BME:VIS)

Jan 18
A Look At The Intrinsic Value Of Viscofan, S.A. (BME:VIS)

Why Viscofan's (BME:VIS) CEO Pay Matters

Dec 26
Why Viscofan's (BME:VIS) CEO Pay Matters

Income Investors Should Know That Viscofan, S.A. (BME:VIS) Goes Ex-Dividend Soon

Dec 13
Income Investors Should Know That Viscofan, S.A. (BME:VIS) Goes Ex-Dividend Soon

Should Viscofan, S.A. (BME:VIS) Be Part Of Your Dividend Portfolio?

Dec 04
Should Viscofan, S.A. (BME:VIS) Be Part Of Your Dividend Portfolio?

The Returns At Viscofan (BME:VIS) Provide Us With Signs Of What's To Come

Nov 19
The Returns At Viscofan (BME:VIS) Provide Us With Signs Of What's To Come

Financial Position Analysis

Short Term Liabilities: VIS's short term assets (€800.7M) exceed its short term liabilities (€359.0M).

Long Term Liabilities: VIS's short term assets (€800.7M) exceed its long term liabilities (€118.9M).


Debt to Equity History and Analysis

Debt Level: VIS's net debt to equity ratio (21.7%) is considered satisfactory.

Reducing Debt: VIS's debt to equity ratio has increased from 18.7% to 27.8% over the past 5 years.

Debt Coverage: VIS's debt is well covered by operating cash flow (54.9%).

Interest Coverage: VIS's interest payments on its debt are well covered by EBIT (29.5x coverage).


Balance Sheet


Discover healthy companies

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.